Q3 EPS Forecast for Dolby Laboratories Boosted by Analyst

Dolby Laboratories, Inc. (NYSE:DLB) – Research analysts at Zacks Research upped their Q3 2025 earnings per share estimates for Dolby Laboratories in a report released on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the electronics maker will earn $0.54 per share for the quarter, up from their previous forecast of $0.53. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. Zacks Research also issued estimates for Dolby Laboratories’ Q4 2025 earnings at $0.54 EPS, Q3 2026 earnings at $0.66 EPS and Q1 2027 earnings at $0.82 EPS.

DLB has been the topic of a number of other reports. StockNews.com cut Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday, January 31st. Barrington Research reiterated an “outperform” rating and set a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday, February 13th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday, January 30th.

Dolby Laboratories Trading Down 1.2 %

Shares of Dolby Laboratories stock opened at $82.36 on Friday. The business’s 50 day simple moving average is $80.56 and its 200-day simple moving average is $76.25. The stock has a market capitalization of $7.86 billion, a price-to-earnings ratio of 30.28 and a beta of 0.98. Dolby Laboratories has a twelve month low of $66.35 and a twelve month high of $89.66.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is 48.53%.

Insider Buying and Selling

In other news, EVP Mark Andrew Sherman sold 40,000 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the completion of the sale, the executive vice president now owns 62,397 shares in the company, valued at approximately $5,296,257.36. This represents a 39.06 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Ryan Nicholson sold 10,500 shares of the stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total value of $841,890.00. Following the sale, the chief accounting officer now owns 24,364 shares of the company’s stock, valued at $1,953,505.52. This trade represents a 30.12 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 126,838 shares of company stock valued at $10,379,431 in the last three months. 38.39% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Dolby Laboratories

Institutional investors and hedge funds have recently modified their holdings of the stock. Bank of New York Mellon Corp lifted its holdings in shares of Dolby Laboratories by 64.2% in the fourth quarter. Bank of New York Mellon Corp now owns 4,826,477 shares of the electronics maker’s stock valued at $376,948,000 after purchasing an additional 1,887,518 shares in the last quarter. Norges Bank purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at $55,356,000. Boston Trust Walden Corp lifted its holdings in shares of Dolby Laboratories by 185.3% in the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock valued at $82,276,000 after purchasing an additional 698,283 shares in the last quarter. Alyeska Investment Group L.P. purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at $27,314,000. Finally, Frontier Capital Management Co. LLC purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at $24,323,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.